The Age-Related Eye Disease Study 2(AREDS2) demonstrated that daily supplementation with 2mg lutein and 10mg zeaxanthin significantly reduces the risk of cataract and advanced age-related macular degeneration (AMD), said Ruan Xin, CBO Business of Kemin China, the sponsor of 2013 CNIC.
Oral supplementation with the Age-Related Eye Disease Study (AREDS) formulation (antioxidant vitamins C and E, beta carotene, and zinc) has been shown to reduce the risk of progression to advanced age-related macular degeneration (AMD). Observational data suggest that increased dietary intake of lutein + zeaxanthin (carotenoids), omega-3 long-chain polyunsaturated fatty acids (docosahexaenoic acid [DHA] + eicosapentaenoic acid [EPA]), or both might further reduce this risk. AREDS2 was designed to test whether adding lutein + zeaxanthin, DHA + EPA, or lutein + zeaxanthin and DHA + EPA to the AREDS formulation might further reduce the risk of progression to advanced AMD. A secondary goal was to test the effects of eliminating beta carotene and reducing zinc dose in the AREDS formulation.
The answer is yes, and when eliminating beta carotene, the effect is better. Oral supplementation with lutein is beneficial to visual performance in healthy people, which is also supported by other studies.
With the support of scientific research and clinical data, Kemin is expanding lutein's application, especially in North America and Asia. As lutein has a beneficial effect on age-related diseases, the old group is the largest consumers. A survey by FROST&SULLIVAN showed that oral supplementation of lutein or zeaxanthin significantly decreases the medicinal expense of age-related diseases, which is up to $1 billion.
Over 70 health products and cosmetics based on lutein have been launched in the world, and players include Wyeth, Shiseido, Bausch& Lomb and Coca Cola.
FloraGLO（R), supported by clinical research, is being sold in more than 90 countries, bringing $550 million to Kemin. FloraGLO（R) is used in more clinical research.
Copyright：Herbridge Media
- White Paper on Bone and Joint Health of Chinese Consumers 2020
- Yili Dairy launched high-protein yogurt, focusing on sport people
- Sinopharm Xingsha launched the Japan's Champion probiotics
- China has introduced its first policy to support the industrial hemp industry
- Beyond Meat became the first overseas Artificial Meat company to set up a factory in China
- Nongfu Spring's market value exceeded HK $370 billion on its first day
- German infant nutrition brand Amykon launched two probiotics in China
- The revenue of Besunyoung in the first half year is about 610 million yuan
- Jellly candy and powder included in the health food filing dosage form in China
- H&H Group net profit increased by 9% for the first half of year
